Reach Us +44-1993-227344
Escitalopram for Delusion in an Oldest Old Patient with Alzheimer's Disease | OMICS International
ISSN: 2168-975X
Brain Disorders & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Escitalopram for Delusion in an Oldest Old Patient with Alzheimer's Disease

Sachiko Yokoyama1, Mari Aoki1, Kazunari Azuma1, Koichi Jimbo1, Kimiko Konishi1, Masaki Okada2, Misa Hosoi1 and Koji Hori1,2*
1Department of Psychiatry, Showa University Northern Yokohama Hospital, Kanagawa, Japan
2Department of Psychiatry, Hitachiumegaoka Hospital, Ibaraki, Japan
Corresponding Author : Koji Hori
Department of Psychiatry
Showa University Northern Yokohama Hospital 35-1 Chigasakichuo
Tsuzukiku, Yokohama, Kanagawa 224-8503, Japan
Tel: +81-45-949-7000
Fax: +81-45-949-7927
E-mail: [email protected]
Received Septembet 18, 2013; Accepted October 23, 2013; Published October 25, 2013
Citation: Yokoyama S,Aoki M, Azuma K, Jimbo K, Konishi K, et al. (2013) Escitalopram for Delusion in an Oldest Old Patient with Alzheimer’s Disease. Brain Disord Ther 2:108. doi:10.4172/2168-975X.1000108
Copyright: © 2013 Yokoyama S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Brain Disorders & Therapy


Objective: To present a case of Alzheimer’s disease (AD) associated with delusions that were satisfactorily treated with escitalopram. Background: In Japan, there are currently no licensed medicines for the management of the behavioral and psychological symptoms of dementia (BPSD) in AD patients. Patient and Results: We present the case of an 88-year-old woman with AD who developed delusions that were successfully treated with escitalopram. We previously reported that anxiety in elderly AD patients was associated with delusions and hallucinations and was caused by disturbance of the serotonergic system. Therefore, we considered that enhancement of the serotonergic system may be useful for ameliorating delusion in the present AD patient. Escitalopram inhibits the reuptake of serotonin and experts allosteric potentiating actions on serotonin reuptake inhibitors, moreover, it has evidence of efficacy for treating affective symptoms in the old patients. Therefore, this agent may be useful for ameliorating serotonin deficiency and delusion in the oldest old AD patients. Conclusions: Escitalopram may be useful for the management of psychotic symptoms in relatively older patients with AD.

Behavioral and psychological symptoms of dementia; Delusion; Alzheimer’s disease; Escitalopram
In Japan, no medicines are currently licensed for the treatment of the Behavioral and Psychological Symptoms of Dementia (BPSD) in patients with Alzheimer’s disease (AD). Although antipsychotics for BPSD symptoms such as delusions, hallucinations, agitation, or aggression are prescribed with consent from the legal representatives of AD patients, atypical antipsychotics are avoided because of the increased mortality rate in patients with AD [1]. Here we report the case of an 88-year-old man with AD whose BPSD symptoms were successfully treated by escitalopram. The patient’s legal representative provided informed consent for the publication of this case report.
Case Presentation
An 88-year-old woman presented at our clinic with a history of amnesia. Six months back, she had fallen down a flight of stairs and sustained a head injury, for which she was admitted to hospital for 3 months. During this period, there were no recorded psychotic problems. Because of her poor memory, she was discharged to the care of her son, who judged that she could not live alone because of amnesic state and moved her to his home. Since discharge (3 months before visiting our memory clinic), she became increasingly confused about her location and developed delusions that someone had entered her house. She believed that her son tried to steal money from her and even reported these events to the police. This behavior prompted her son to bring her to our memory clinic for further investigation.
On examination, her Mini-Mental State Examination (MMSE) sore was 11. Brain computed tomography showed the possibility of atrophy of the parahippocampal cortex and a low-density area in the right frontal cortex. She was diagnosed with AD. However, we considered that her delusions resulted from her symptoms of anxiety. Therefore, we prescribed 10 mg of escitalopram for a month. Although this treatment ameliorated her delusions, the degree of amnesia remained unchanged.
The 88-year-old woman reported in this case study was diagnosed with AD on the basis of pre-existing symptoms at the time of the head injury and the lack of symptoms, including delirium, during her hospital stay. We believe that although her head injury caused amnesia and worsened her ability to perform her activities of daily living; this injury was not related to her psychotic state. She also had no psychiatric problems soon after discharge from the hospital. We considered that she became delusional after discharge because she was very unfamiliar with the environment in her son’s home as a result of her AD. We previously reported that in relatively older AD patients, affective disturbance was associated with aggressiveness while anxiety was associated with delusions and hallucinations using the factor analysis method [2]; this indicated that aging affected BPSD in AD patients, connecting psychotic and depressive symptoms. We also reported that the division of AD patients divided into relatively high and relatively low cognitive performance groups, affective disturbance and anxiety were associated with aggressiveness, delusions, and hallucinations in the latter group [3]; this indicated that AD progression also affected BPSD, connecting psychotic and depressive symptoms.
The above mentioned features were related to mixed states of depression and mania because manic symptoms (aggressiveness, delusions, and hallucinations) were connected with depressive symptoms such as anxiety [4]. Indeed, Ng et al. [4] and Dorey et al. [5] commented that BPSD may be related to bipolarity. Therefore, we speculate that the delusions in the current patient may actually represent a hidden anxiety symptom compounded by the AD state. This finding supported the basis that anxiety in oldest old patients with AD is associated with delusions and hallucinations [2].
On the basis of these assertions, physicians should prescribe augmentation medications for BPSD [6]. However, the oldest old are more vulnerable to the adverse effects of antipsychotics, which should therefore be avoided for these patients. Some reports have demonstrated the effectiveness of antidepressants against behavioral symptoms, e.g., selective serotonin reuptake inhibitors, which are particularly prescribed for delusions in patients with dementia [7,8]. Therefore, we prescribed escitalopram for the current patient.
Anxiety is believed to be related to serotonin deficiency [9]. The main symptom in our patient was delusion that we considered to be related to anxiety; moreover, her symptoms were severe enough to justify rapid treatment response. Escitalopram inhibits serotonergic reuptake and exerts allosteric potentiating effects on serotonin reuptake inhibitors [10], making it suitable for causing a rapid and steady increase in serotonin levels. This agent is also suitable for elderly patients; therefore, we prescribed it for the current patient. Our report demonstrates that delusion in the oldest old with AD may be related to anxiety and that antidepressants are a potential therapeutic strategy for BPSD in the oldest old.
Conflicts of Interest
Koji Hori received lecture fees from Eisai Co., Ltd.; Pfizer Japan Inc.; Novartis Pharma K.K.; Daiichi Sankyo Inc.; Ono Pharmacuetical Co., Ltd.; Janssen Pharmaceutical K.K.; Yoshitomi Yakuhin Co.; and Mitsubishi Tanabe Pharma Co.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • Brain-2018[World Brain Congress]
    December 5-7, 2018 Dubai, UAE

Article Usage

  • Total views: 11836
  • [From(publication date):
    November-2013 - Oct 21, 2018]
  • Breakdown by view type
  • HTML page views : 8048
  • PDF downloads : 3788

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7